» Articles » PMID: 35748700

Deciphering Signal Transduction Networks in the Liver by Mechanistic Mathematical Modelling

Overview
Journal Biochem J
Specialty Biochemistry
Date 2022 Jun 24
PMID 35748700
Authors
Affiliations
Soon will be listed here.
Abstract

In health and disease, liver cells are continuously exposed to cytokines and growth factors. While individual signal transduction pathways induced by these factors were studied in great detail, the cellular responses induced by repeated or combined stimulations are complex and less understood. Growth factor receptors on the cell surface of hepatocytes were shown to be regulated by receptor interactions, receptor trafficking and feedback regulation. Here, we exemplify how mechanistic mathematical modelling based on quantitative data can be employed to disentangle these interactions at the molecular level. Crucial is the analysis at a mechanistic level based on quantitative longitudinal data within a mathematical framework. In such multi-layered information, step-wise mathematical modelling using submodules is of advantage, which is fostered by sharing of standardized experimental data and mathematical models. Integration of signal transduction with metabolic regulation in the liver and mechanistic links to translational approaches promise to provide predictive tools for biology and personalized medicine.

Citing Articles

Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease.

Burbano de Lara S, Kemmer S, Biermayer I, Feiler S, Vlasov A, DAlessandro L Mol Syst Biol. 2024; 20(3):187-216.

PMID: 38216754 PMC: 10912216. DOI: 10.1038/s44320-023-00007-4.


Uncovering specific mechanisms across cell types in dynamical models.

Hauber A, Rosenblatt M, Timmer J PLoS Comput Biol. 2023; 19(9):e1010867.

PMID: 37703301 PMC: 10519600. DOI: 10.1371/journal.pcbi.1010867.

References
1.
Adlung L, Kar S, Wagner M, She B, Chakraborty S, Bao J . Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation. Mol Syst Biol. 2017; 13(1):904. PMC: 5293153. DOI: 10.15252/msb.20167258. View

2.
Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot A, Copin M . The multiple paths towards MET receptor addiction in cancer. Oncogene. 2018; 37(24):3200-3215. DOI: 10.1038/s41388-018-0185-4. View

3.
Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K . Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer. 2001; 84(10):1377-83. PMC: 2363640. DOI: 10.1054/bjoc.2000.1580. View

4.
Qu L, Lemon S . Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin Liver Dis. 2010; 30(4):319-32. DOI: 10.1055/s-0030-1267534. View

5.
Speicher T, Siegenthaler B, Bogorad R, Ruppert R, Petzold T, Padrissa-Altes S . Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling. Nat Commun. 2014; 5:3862. DOI: 10.1038/ncomms4862. View